Solaris Endovascular announced 12-month results from the Solaris SX iliac postmarket clinical follow-up study of the company&rs ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

Penumbra Inc. announced it has secured CE Mark approval for its Lightning Bolt 12 and Lightning Bolt 6X with Trax. These next-g ...

Angiolutions announced that the first patient has been treated in a first-in-human (FIH) study evaluating the safety and ...

Rampart IC, a developer of radiation shielding for interventional suites, announced new data on the reduction in radiation ...

Bentley InnoMed GmbH, which is headquartered in Hechingen, Germany, announced the first-in-human use of the company’s BeG ...

Akura Medical, a Shifamed portfolio company focused on venous thromboembolism care, announced it has secured a $53 million firs ...

Enhanced angioplasty with focal force technology now offers a proven path to achieving more effective and durable results.

Royal Philips announced the expanded commercial availability of its LumiGuide device guidance across Europe and the United Stat ...